Table 7.
Subgroup analysis on characteristics of stroke patients with and without COVID-19 infection.
| References | Male,% | Female, % | Age was presented either in mean ± standard deviation or median (Interquartile range), or mean (range) | Comorbidities and smoking habit | Mortality rate, % | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diabetes, % | Hyperlipidemia, % | Hypertension, % | Ischemic heart disease, % | Heart failure, % | Previous stroke, % | Chronic kidney disease/ end-stage renal disease, % | Malignancy, % | Atrial fibrillation, % | Smoking, % | |||||||||||||||||||
| Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | Stroke C+ | Stroke C- | |
| Benussi et al. (33) | 51.2 | 58.8 | 48.8 | 41.2 | 75.9 (range = 66.8–85.2) | 74.8 (range = 58.3–80.4) | 23.3 | 20.6 | 23.3 | 33.8 | 60.5 | 75 | 18.6 | 11.8 | N/A | N/A | N/A | N/A | 4.7 | 4.4 | 11.6 | 27.9 | N/A | N/A | 2.3 | 8.8 | 34.9 | 5.9 |
| Yaghi et al. (36) | 71.9 | 52.2 | 28.1 | 48.8 | 63 (IQR=17) | 70 (IQR = 18) | 34.4 | 28.3 | 56.3 | 50 | 56.6 | 76.1 | 15.6 | 26.1 | 6.3 | 10.9 | 3.1 | 13.0 | N/A | N/A | N/A | N/A | 18.8 | 21.7 | 0 | 4.3 | 63.6 | 9.3 |
| Escalard et al. (37) | 80 | 48 | 20 | 52 | 59.5 (range = 54) | 72 (range = 60–81.5) | 40 | 22 | 30 | 37 | 50 | 55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 10 | 30 | 10 | 26 | 60 | 11 |
Stroke C+: Stroke patients with COVID-19 infection; Stroke C-: Stroke patients without COVID-19 infection. N/A: Not available.